Supramolecular Combination Cancer Therapy Based on Macrocyclic Supramolecular Materials
Супрамолекулярная комбинированная терапия рака на основе макроциклических супрамолекулярных материалов
2022-11-11
SCID: 54.1/g7pvvbph
Discuss with AI
gene chemotherapyhost–guest interactionmacrocyclic supramolecular materialsphotothermal chemotherapysupramolecular combination therapy
Figures from the paper
Abstract (AI)
Supramolecular combination therapy adopts supramolecular materials to design intelligent drug delivery systems with different strategies for cancer treatments. Thereinto, macrocyclic supramolecular materials play a crucial role in encapsulating anticancer drugs to improve anticancer efficiency and decrease toxicity towards normal tissue by host-guest interaction. In general, chemotherapy is still common therapy for solid tumors in clinics. However, supramolecular combination therapy can overcome the limitations of the traditional single-drug chemotherapy in the laboratory findings. In this review, we summarized the combination chemotherapy, photothermal chemotherapy, and gene chemotherapy based on macrocyclic supramolecular materials. Finally, the application prospects in supramolecular combination therapy are discussed.
Key Findings
1
Macrocyclic supramolecular materials enable host–guest encapsulation of anticancer drugs, potentially improving efficacy while reducing toxicity to normal tissues.
2
Supramolecular combination therapy addresses limitations of conventional single-drug chemotherapy for solid tumors, based on laboratory findings.
3
The paper discusses future application prospects and challenges for macrocyclic supramolecular materials in supramolecular combination cancer therapy.
4
The review covers macrocycle-based combination chemotherapy, photothermal chemotherapy, and gene chemotherapy strategies.
Research Object
macrocyclic supramolecular materials used in cancer drug-delivery systems
Research Subject
supramolecular combination cancer-therapy strategies, including combination chemotherapy, photothermal chemotherapy, and gene chemotherapy, with improved anticancer efficacy and reduced toxicity
Publication Details
Publication Date
2022-11-11
Journal
Publisher
ISSN
Cited by
16
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest